Literature DB >> 21654550

Cannabidiol reduces brain damage and improves functional recovery after acute hypoxia-ischemia in newborn pigs.

Hector Lafuente1, Francisco J Alvarez, M Ruth Pazos, Antonia Alvarez, M Carmen Rey-Santano, Victoria Mielgo, Xabier Murgia-Esteve, Enrique Hilario, José Martinez-Orgado.   

Abstract

Newborn piglets exposed to acute hypoxia-ischemia (HI) received i.v. cannabidiol (HI + CBD) or vehicle (HI + VEH). In HI + VEH, 72 h post-HI brain activity as assessed by amplitude-integrated EEG (aEEG) had only recovered to 42 ± 9% of baseline, near-infrared spectroscopy (NIRS) parameters remained lower than normal, and neurobehavioral performance was abnormal (27.8 ± 2.3 points, normal 36). In the brain, there were fewer normal and more pyknotic neurons, while astrocytes were less numerous and swollen. Cerebrospinal fluid concentration of neuronal-specific enolase (NSE) and S100β protein and brain tissue percentage of TNFα(+) cells were all higher. In contrast, in HI + CBD, aEEG had recovered to 86 ± 5%, NIRS parameters increased, and the neurobehavioral score normalized (34.3 ± 1.4 points). HI induced histological changes, and NSE and S100β concentration and TNFα(+) cell increases were suppressed by CBD. In conclusion, post-HI administration of CBD protects neurons and astrocytes, leading to histological, functional, biochemical, and neurobehavioral improvements.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21654550     DOI: 10.1203/PDR.0b013e3182276b11

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  34 in total

Review 1.  Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?

Authors:  Javier Fernández-Ruiz; Onintza Sagredo; M Ruth Pazos; Concepción García; Roger Pertwee; Raphael Mechoulam; José Martínez-Orgado
Journal:  Br J Clin Pharmacol       Date:  2013-02       Impact factor: 4.335

Review 2.  Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders.

Authors:  Orrin Devinsky; Maria Roberta Cilio; Helen Cross; Javier Fernandez-Ruiz; Jacqueline French; Charlotte Hill; Russell Katz; Vincenzo Di Marzo; Didier Jutras-Aswad; William George Notcutt; Jose Martinez-Orgado; Philip J Robson; Brian G Rohrback; Elizabeth Thiele; Benjamin Whalley; Daniel Friedman
Journal:  Epilepsia       Date:  2014-05-22       Impact factor: 5.864

3.  Cannabidiol reduces lung injury induced by hypoxic-ischemic brain damage in newborn piglets.

Authors:  Luis Arruza; Maria Ruth Pazos; Nagat Mohammed; Natalia Escribano; Hector Lafuente; Martín Santos; Francisco J Alvarez-Díaz; William Hind; Jose Martínez-Orgado
Journal:  Pediatr Res       Date:  2017-05-03       Impact factor: 3.756

Review 4.  Perinatal hypoxic-ischemic brain injury in large animal models: Relevance to human neonatal encephalopathy.

Authors:  Raymond C Koehler; Zeng-Jin Yang; Jennifer K Lee; Lee J Martin
Journal:  J Cereb Blood Flow Metab       Date:  2018-08-28       Impact factor: 6.200

5.  Short-term effects of cannabidiol after global hypoxia-ischemia in newborn piglets.

Authors:  Håvard T Garberg; Marianne U Huun; Javier Escobar; Jose Martinez-Orgado; Else-Marit Løberg; Rønnaug Solberg; Ola Didrik Saugstad
Journal:  Pediatr Res       Date:  2016-07-21       Impact factor: 3.756

6.  Cannabidiol Exposure During Neuronal Differentiation Sensitizes Cells Against Redox-Active Neurotoxins.

Authors:  Patrícia Schönhofen; Liana M de Medeiros; Ivi Juliana Bristot; Fernanda M Lopes; Marco A De Bastiani; Flávio Kapczinski; José Alexandre S Crippa; Mauro Antônio A Castro; Richard B Parsons; Fábio Klamt
Journal:  Mol Neurobiol       Date:  2014-08-10       Impact factor: 5.590

Review 7.  Cannabinoids in Neurodegenerative Disorders and Stroke/Brain Trauma: From Preclinical Models to Clinical Applications.

Authors:  Javier Fernández-Ruiz; María A Moro; José Martínez-Orgado
Journal:  Neurotherapeutics       Date:  2015-10       Impact factor: 7.620

8.  Protective effects of cannabidiol against hippocampal cell death and cognitive impairment induced by bilateral common carotid artery occlusion in mice.

Authors:  Angélica Pupin Schiavon; Lígia Mendes Soares; Jéssica Mendes Bonato; Humberto Milani; Francisco Silveira Guimarães; Rúbia Maria Weffort de Oliveira
Journal:  Neurotox Res       Date:  2014-02-15       Impact factor: 3.911

Review 9.  Cannabinoid-Based Therapies and Brain Development: Potential Harmful Effect of Early Modulation of the Endocannabinoid System.

Authors:  Patrícia Schonhofen; Ivi Juliana Bristot; José Alexandre Crippa; Jaime Eduardo Cecílio Hallak; Antônio Waldo Zuardi; Richard B Parsons; Fábio Klamt
Journal:  CNS Drugs       Date:  2018-08       Impact factor: 5.749

Review 10.  Is the cardiovascular system a therapeutic target for cannabidiol?

Authors:  Christopher P Stanley; William H Hind; Saoirse E O'Sullivan
Journal:  Br J Clin Pharmacol       Date:  2013-02       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.